Top Markets
Coin of the day
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Rang in aandelen #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Aandeelprijs
$12.94
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$1.10B
Verandering (1 dag)
-0.16%
Verandering (1 jaar)
-51.50%
Land
US
Handel Kolon TissueGene, Inc. (950160)

Categorie

Koersgeschiedenis voor Kolon TissueGene, Inc. (950160)
Hoogste slotkoers: $14.96 op 2026-08-01

Laagste slotkoers: $50.89 op 2017-11-01
Koersgeschiedenis van Kolon TissueGene, Inc. van 2017 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -2.28%
2025 232.88%
2024 144.93%
2023 -18.79%
2022 -12.44%
2019 -73.89%
2018 -22.36%
2017 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH